AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2011

Sep 29, 2011

32870_dirs_2011-09-29_ea08ae50-5837-4368-8538-5f698c87da32.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2011-09-19

Reporting Person: Kramer Robert (Interim, EVP, BioSciences)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1565043	Indirect

Footnotes

F1: An entity named "RKRAMER, L.L.C." which is wholly owned by Mr. Kramer holds 21.01% of the equity interest in BioPharm, L.L.C. BioPharm, L.L.C. is the direct owner of 1,565,043 shares of Common Stock. Mr. Kramer disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuinary interest in 328,816.